Exclusive

Publication

Byline

Location

US Patent Issued to EMORY UNIVERSITY on Oct. 27 for "Coronavirus vaccines, compositions, and methods related thereto" (Georgia Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,450, issued on Oct. 27, was assigned to EMORY UNIVERSITY (Atlanta). "Coronavirus vaccines, compositions, and methods related thereto" was i... Read More


US Patent Issued to University of Florida Research Foundation on Oct. 27 for "Methods of tolerizing a subject to a viral vector" (Florida Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,451, issued on Oct. 27, was assigned to University of Florida Research Foundation Inc. (Gainesville, Fla.). "Methods of tolerizing a subjec... Read More


US Patent Issued to TCR2 THERAPEUTICS on Oct. 27 for "Compositions and methods for TCR reprogramming using CD70 specific fusion proteins" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,452, issued on Oct. 27, was assigned to TCR2 THERAPEUTICS INC. (Cambridge, Mass.). "Compositions and methods for TCR reprogramming using CD... Read More


US Patent Issued on Oct. 27 for "Fluorescent systems for biological imaging and uses thereof" (British Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,453, issued on Oct. 27. "Fluorescent systems for biological imaging and uses thereof" was invented by Andrew Whiting (Wynyard Billingham Du... Read More


US Patent Issued to Acura Pharmaceuticals on Oct. 27 for "Methods and compositions for self-regulated release of active pharmaceutical ingredient" (Maryland, Georgia Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,454, issued on Oct. 27, was assigned to Acura Pharmaceuticals Inc. (Palatine, Ill.). "Methods and compositions for self-regulated release o... Read More


US Patent Issued to AstraZeneca on Oct. 27 for "Stable, aqueous formulations of antibodies that bind IL5 receptor" (Maryland Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,455, issued on Oct. 27, was assigned to AstraZeneca AB (Sodertalje, Sweden). "Stable, aqueous formulations of antibodies that bind IL5 rece... Read More


US Patent Issued to Cella Therapeutics on Oct. 27 for "Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (FAS) or FAS ligand (FASL) inhibitor, a tumor necrosis factor-Alpha (TNF-Alpha) or TNF receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease inhibitor" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,456, issued on Oct. 27, was assigned to Cella Therapeutics LLC (Miami). "Drug delivery systems comprising a neurotrophic agent, an apoptosi... Read More


US Patent Issued to SIGILON THERAPEUTICS on Oct. 27 for "Implantable devices for cell therapy and related methods" (Massachusetts, Texas, Rhode Island, Illinois Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,457, issued on Oct. 27, was assigned to SIGILON THERAPEUTICS INC. (Cambridge, Mass.). "Implantable devices for cell therapy and related met... Read More


US Patent Issued to BIOHAVEN THERAPEUTICS on Oct. 27 for "Directed conjugation technologies" (Connecticut Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,458, issued on Oct. 27, was assigned to BIOHAVEN THERAPEUTICS LTD. (New Haven, Conn.). "Directed conjugation technologies" was invented by ... Read More


US Patent Issued to Spectrum Pharmaceuticals on Oct. 27 for "Methods of treatment using g-CSF protein complex" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,459, issued on Oct. 27, was assigned to Spectrum Pharmaceuticals Inc. (Lake Forest, Ill.). "Methods of treatment using g-CSF protein comple... Read More